| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.1 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.044 | 0.1 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.2 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |